Comprehensive, easy-to-understand information about this condition
How we create this content →The documentation for ALS1 is limited due to its rarity and the complexity of its clinical presentation. As ALS1 affects a relatively small number of individuals, systematic clinical studies have been sparse. Additionally, the genetic basis was only recently identified, and ongoing research is necessary to fully characterize its clinical features and progression.
To navigate your journey with ALS1, consider consulting a neurologist with expertise in motor neuron diseases. Genetic counseling may also be beneficial given the genetic implications of the SOD1 gene. For additional resources, you can explore the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov. Participating in clinical trials could provide access to new therapies and contribute to the understanding of ALS1.
There are currently 275 active clinical trials related to amyotrophic lateral sclerosis type 1. While there are no orphan drug designations, the extensive number of trials indicates significant research interest in this condition. For more information on ongoing studies, you can search at ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=amyotrophic%20lateral%20sclerosis%20type%201.
Actionable guidance for navigating care for amyotrophic lateral sclerosis type 1
To navigate your journey with ALS1, consider consulting a neurologist with expertise in motor neuron diseases. Genetic counseling may also be beneficial given the genetic implications of the SOD1 gene. For additional resources, you can explore the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov. Participating in clinical trials could provide access to new therapies and contribute to the understanding of ALS1.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for ALS1 is limited due to its rarity and the complexity of its clinical presentation. As ALS1 affects a relatively small number of individuals, systematic clinical studies have been sparse. Additionally, the genetic basis was only recently identified, and ongoing research is necessary to fully characterize its clinical features and progression.
To navigate your journey with ALS1, consider consulting a neurologist with expertise in motor neuron diseases. Genetic counseling may also be beneficial given the genetic implications of the SOD1 gene. For additional resources, you can explore the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov. Participating in clinical trials could provide access to new therapies and contribute to the understanding of ALS1.
There are currently 275 active clinical trials related to amyotrophic lateral sclerosis type 1. While there are no orphan drug designations, the extensive number of trials indicates significant research interest in this condition. For more information on ongoing studies, you can search at ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=amyotrophic%20lateral%20sclerosis%20type%201.
Actionable guidance for navigating care for amyotrophic lateral sclerosis type 1
To navigate your journey with ALS1, consider consulting a neurologist with expertise in motor neuron diseases. Genetic counseling may also be beneficial given the genetic implications of the SOD1 gene. For additional resources, you can explore the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov. Participating in clinical trials could provide access to new therapies and contribute to the understanding of ALS1.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
The documentation for ALS1 is limited due to its rarity and the complexity of its clinical presentation. As ALS1 affects a relatively small number of individuals, systematic clinical studies have been sparse. Additionally, the genetic basis was only recently identified, and ongoing research is necessary to fully characterize its clinical features and progression.
To navigate your journey with ALS1, consider consulting a neurologist with expertise in motor neuron diseases. Genetic counseling may also be beneficial given the genetic implications of the SOD1 gene. For additional resources, you can explore the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov. Participating in clinical trials could provide access to new therapies and contribute to the understanding of ALS1.
There are currently 275 active clinical trials related to amyotrophic lateral sclerosis type 1. While there are no orphan drug designations, the extensive number of trials indicates significant research interest in this condition. For more information on ongoing studies, you can search at ClinicalTrials.gov: https://clinicaltrials.gov/search?cond=amyotrophic%20lateral%20sclerosis%20type%201.
Actionable guidance for navigating care for amyotrophic lateral sclerosis type 1
To navigate your journey with ALS1, consider consulting a neurologist with expertise in motor neuron diseases. Genetic counseling may also be beneficial given the genetic implications of the SOD1 gene. For additional resources, you can explore the Genetic and Rare Diseases Information Center at rarediseases.info.nih.gov. Participating in clinical trials could provide access to new therapies and contribute to the understanding of ALS1.
Consider asking your healthcare providers these condition-specific questions
Helpful links for rare disease information and support
Inheritance patterns describe how genetic conditions are passed from parents to children.
Research studies investigating treatments and therapies for this condition.
Active Trials
Total Trials
Data from ClinicalTrials.gov Jan 31, 2026
Consider asking your healthcare providers these condition-specific questions
Online Mendelian Inheritance in Man
AI-Generated Content: This summary was generated using AI. Content has been fact-checked. Always consult with qualified healthcare providers for medical guidance.
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.